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A B S T R A C T
The ongoing and widespread emergence of resistance to the existing anti-nematodal pharmacopeia has made it
imperative to develop new anthelminthic agents. Historically, plants have been important sources of therapeutic
compounds and offer an alternative to synthetic drugs. Monoterpenoids are phytochemicals that have been shown to
produce acute toxic effects in insects and nematodes. Previous studies have shown nicotinic acetylcholine receptors
(nAChRs) to be possible targets for naturally occurring plant metabolites such as carvacrol and carveol. In this study
we examined the effects of monoterpenoid compounds on a levamisole sensitive nAChR from Oesophagostomum
dentatum and a nicotine sensitive nAChR from Ascaris suum. We expressed the receptors in Xenopus laevis oocytes and
used two-electrode voltage-clamp to characterize the effect of various compounds on these cys-loop receptors. At
100 μM the majority of these compounds acted as antagonists. Interestingly, further experiments revealed that both
0.1 μM and 10 μM menthol potentiated acetylcholine and levamisole responses in the levamisole sensitive receptor
but not the nicotine sensitive receptor. We also investigated the effects of 0.1 μM menthol on the contractility of A.
suum somatic muscle strips. Menthol produced significant potentiation of peak contractions at each concentration of
acetylcholine. The positive allosteric modulatory effects of menthol in both in vivo and in vitro experiments suggests
menthol as a promising candidate for combination therapy with cholinergic anthelmintics.
1. Introduction
Parasitic nematode infections are a threat to health and have sig-
nificant socio-economic consequences. Among the different classes of
nematodes, soil transmitted helminths (STHs) are major contributors to
the global parasite burden. According to WHO (2018), more than 1.5
billion people, or 24% of the world's population, are infected with at least
one species of soil transmitted helminth, which mainly include Ascaris
lumbricoides, Trichuris trichiura and hookworms (Necator americanus and
Ancylostoma duodenale). These infections are most commonly found in
tropical and sub-tropical countries due to suboptimal sanitation, lack of
access to clean water and favorable climatic conditions for the parasites
(Bethony et al., 2006; Brooker et al., 2006; Hotez et al., 2008; Savioli and
Albonico, 2004). Although mortality is rare, high morbidity is a common
feature of intestinal helminthiasis. The disease manifestations include
weight loss, anemia, diarrhea, abdominal pain, malnutrition, general
malaise, weakness, as well as impaired growth and physical development
(Bethony et al., 2006). Children bear the highest burden of these
infections which profoundly affect their physical growth, cognitive de-
velopment and cause educational deficits (Alum et al., 2010; Brooker,
2010; Stephenson et al., 2000). STH infections such as Ascariasis have
also been reported to exacerbate other diseases such as malaria, tu-
berculosis and HIV/AIDS (Fincham et al., 2003; Le Hesran et al., 2004).
In addition, production losses caused by intestinal nematodes of livestock
have adverse effects on nutritional status and the food economy espe-
cially in poverty-stricken regions (Morgan et al., 2013).
Effective vaccines are the most desirable approach but even after
almost 30 years of dedicated research, a licensed vaccine against human
parasites remains elusive. Current control strategies for treatment and
prevention of helminth infections rely heavily on chemotherapy.
Unfortunately, there are a limited number of classes of anthelmintic
agents, which include benzimidazoles, macrocyclic lactones and nico-
tinic agonists (Abongwa et al., 2017; Martin, 1997; Robertson and
Martin, 2007). Moreover, widespread and indiscriminate administra-
tion combined with genetic factors has led to the development of re-
sistance in animals (Albonico et al., 2003; Taman and Azab, 2014).
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There have also been reports of reduced therapeutic efficacy to anti-
nematodal drugs in humans. De Clercq et al. (1997) and Flohr et al.
(2007) reported poor efficacy of benzimidazoles against human hook-
worm infections. There is a need to focus research on drug discovery
and development to overcome the issue of increasing resistance and
reduced efficacy against existing drugs.
The use of phytotherapeutics for parasitic infections has emerged as an
attractive alternative. Plants have dominated the human pharmacopoeia
for thousands of years (Balick and Cox, 1996; Newman and Cragg, 2016;
Raskin and Ripoll, 2004). Many therapeutic products, including codeine,
quinine, artemisinin, digitoxin, morphine, paclitaxel, galantamine, cur-
rently used in modern pharmacotherapy are of plant origin (Butler, 2004;
Heinrich and Lee Teoh, 2004; Newman and Cragg, 2016; Newman et al.,
2000; Petrovska, 2012; Pirttila et al., 2004; Samuelsson, 2004). Plant
based therapeutic compounds are environment-friendly and exhibit a wide
array of medicinal properties (Balunas and Kinghorn, 2005; Coats, 1994;
Dias et al., 2012; Harvey et al., 2015; Hu and Coats, 2008). Interestingly,
an estimated four billion people living in the developing world rely on
medicinal plants for their primary pharmaceutical care (WHO, 2005).
Herbal remedies in the form of complementary and alternative medicine
(CAM) are also being widely embraced in many developed countries
(Anquez-Traxler, 2011; Calapai, 2008; Committee on the Use of
Complementary and Alternative Medicine by the American Public, 2005).
Among phytochemicals, essential oils and their active principles have been
well documented for their broad range of functions including insecticidal
and nematocidal activities (Camurca-Vasconcelos et al., 2007; Cetin et al.,
2009; Coskun et al., 2008; Enan, 2005; Macedo et al., 2009; Panella et al.,
2005). Historically, thymol (found in oil of thyme), santonin (derived from
buds of the local Artemisia spp.) and ascaridol (isolated from Chenopodium
oil) were used in the late nineteenth and early twentieth century for the
treatment of ascarids and hookworms in humans (Ferrell, 1914; Kaplan
et al., 2014; Lamson and Ward, 1932). Terpene and terpenoid biomole-
cules, particularly monoterpenes and sesquiterpenes, found in essential
oils have been identified as promising anthelmintic compounds and are of
great pharmaceutical interest (Jaradat et al., 2016; Katiki et al., 2011; Lei
et al., 2010; Pessoa et al., 2002; Squires et al., 2010). Lei et al. (2010)
reported in vitro nematocidal activity of thymol and carvacrol (major
components of thyme and oregano essential oils) against Caenorhabditis
elegans and Ascaris suum. Trailović et al. (2015) also demonstrated the
potential anthelmintic effects of carvacrol in A. suum.
In the present study, we tested the activity of monoterpenoid
compounds on two different nematode nAChR types: levamisole sen-
sitive (L-type) nAChRs from Oesophagostomum dentatum and a nicotine
sensitive (N-type) nAChR (ACR-16) from A. suum. The receptors were
expressed in Xenopus laevis oocytes and we used two-electrode voltage-
clamp to study the pharmacological effects of the compounds. We also
investigated the effects of menthol on the contractility of A. suum so-
matic muscle strips. The focus of this study was to evaluate the effects
produced by monoterpenoid compounds to identify potential alter-
natives to current chemotherapeutic agents.
2. Materials and methods
2.1. cRNA preparation and X. laevis oocyte expression
All nAChR subunit and ancillary factor cRNAs from O. dentatum (Ode-
unc-29, Ode-unc-38, Ode-unc-63 and Ode-acr-8), A. suum (Asu-acr-16 and
Asu-ric-3) and Haemonchus contortus (Hco-ric-3, Hco-unc-50 and Hco-unc-
74) were prepared as previously described (Abongwa et al., 2016b; Buxton
et al., 2014). The receptors were expressed in defolliculated X. laevis oo-
cytes purchased from Ecocyte Bioscience (Austin, Texas, USA). N-type
(nicotine sensitive) nAChRs from A. suum were expressed by co-injecting
25 ng of Asu-acr-16 with 5 ng of Asu-ric-3 in a total volume of 50 nL in
nuclease-free water. Heteromeric (levamisole sensitive) nAChRs from O.
dentatum were expressed by co-injecting 1.8 ng of each subunit cRNA
(Ode-unc-29, Ode-unc-38, Ode-unc-63 and Ode-acr-8) with 1.8 ng of each H.
contortus ancillary factor (Hco-ric-3, Hco-unc-50 and Hco-unc-74) in a total
volume of 36 nL in nuclease-free water. The injections were made in the
animal pole of the oocytes using a nanoject II microinjector (Drummond
Scientific, Broomall, PA, USA). The injected oocytes were separated into
96-well plates containing 200 μL incubation solution (100mMNaCl, 2mM
KCl, 1.8mM CaCl2.2H20, 1mM MgCl2.6H20, 5mM HEPES, 2.5mM Na
pyruvate, 100 U·mL−1 penicillin and 100 μgmL−1 streptomycin, pH 7.5);
each well contained one oocyte. The solution was changed daily to
maintain oocytes in optimal conditions. The oocytes were incubated at
19 °C for 5–7 days to allow functional expression of the receptor.
2.2. Two-electrode voltage-clamp (TEVC) electrophysiology
We used two-electrode voltage-clamp electrophysiology to record the
inward current generated by the activation of expressed receptors in X.
laevis oocytes. The oocytes were incubated with 100 μM BAPTA-AM (an
intracellular calcium chelator) for ∼3h prior to recordings to prevent ac-
tivation of endogenous calcium-activated chloride currents. The oocytes
were clamped at −60mV for all the experiments with an Axoclamp 2B
amplifier; all data were acquired on a desktop computer with Clampex 10.2
(Molecular Devices Inc., CA, USA). The microelectrodes used to impale
oocytes were pulled using a Flaming/Brown horizontal micropipette puller
(model P-97, Sutter Instruments Co., USA) and filled with 3M KCl. The tips
of the microelectrodes were carefully broken with a tissue paper to achieve
a resistance of 2–5MΩ in recording solution (100mM NaCl, 2.5mM KCl,
1mM CaCl2·2H2O and 5mM HEPES, pH 7.3). The low resistance allowed
passage of large currents required to maintain adequate voltage-clamp of
the oocyte. Oocytes were placed into a tiny groove of the narrow oocyte-
recording chamber. The Digidata 1322A (Molecular Devices, CA, USA) was
used to control the switches that controlled the perfusion of the chamber at
a speed of ∼6mL/min. Un-injected oocytes served as the negative control.
2.3. A. suum muscle flap contraction measurements
The adult female A. suum worms were collected from the slaugh-
terhouse at Surčin, Belgrade, Serbia and maintained at 32 °C in Locke's
solution (NaCl 155mM, KCl 5mM, CaCl2 2mM, NaHCO3 1.5mM and
glucose 5mM). The Locke's solution was changed twice daily. Each
batch of worms was used within 4 days of collection. For contraction
studies, A. suum muscle flaps were prepared as described in Trailović
et al. (2015). Briefly, an anterior part of the worm, 2–3 cm caudal to the
head was dissected to prepare a 1 cm muscle flap and the lateral line
was removed from the edge of the flaps. Each muscle flap was attached
to a force transducer in an experimental bath maintained at 37 °C,
containing 20mL Ascaris Perienteric Fluid Ringer (23mM NaCl,
110mM Na acetate, 24mM KCl, 6mM CaCl2, 5 mM MgCl2, 11mM
glucose, 5 mM HEPES, pH 7.6) and bubbled with room air. The iso-
metric contractions were monitored on a PC computer using a BioSmart
Abbreviations
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BAPTA-AM 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N'-tetraacetic
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interface with eLAB software (EIUnit, Belgrade). The preparations were
allowed to equilibrate for 15min under an initial tension of 0.5 g fol-
lowing which acetylcholine (1–100 μM) in the absence and presence of
menthol (0.1 μM) was applied to the preparation. The responses for
each concentration were expressed in grams (g).
2.4. Drug applications
Acetylcholine chloride, L-menthol, (−)-menthone, eugenol, (S)-(−)-β-
Citronellol, (+)-limonene oxide, carvacrol, ((R)-(−))-carvone, menthyl
acetate, phenethyl propionate, trans-cinnamaldehyde and BAPTA-AM
were purchased from Sigma-Aldrich (St Louis, MO, USA). (+)-Pulegone
was purchased from Kodak (Rochester, NY, USA) and geraniol from Berje
(Carteret, NJ, USA). Acetylcholine was dissolved in recording solution
while monoterpenoid compounds (Fig. 1) were dissolved in DMSO such
that the final working concentration did not exceed 0.1%.
Oocytes were perfused with drugs by an 8-channel system (VC-8
valve controller) (Warner Instruments, USA) at a flow rate of ∼6mL/
min. For the agonist experiments, all the essential oils were used at a
concentration of 100 μM. All the responses were normalized to the
Fig. 1. Chemical structures of monoterpenoid compounds used in the present study.
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control (100 μM acetylcholine) response. Each drug was applied for 10s
and the wash off time between each drug was 2min. The application
sequence of agonists for determining the potency series was random
and not predetermined. The concentration-response relationship for
acetylcholine was generated by applying increasing concentrations of
acetylcholine (0.1–300 μM) for 10 s.
For positive allosteric modulator experiments, we tested the effects
of menthol (0.1 and 10 μM) on acetylcholine and levamisole con-
centration-response relationships. Control concentration-responses
were obtained by applying ascending concentrations of the agonist for
10 s. Concentration-response relationships in the presence of 0.1 μM
and 10 μM menthol were generated by first applying a control 100 μM
acetylcholine for 10 s, followed by a 2-min application of menthol, and
10 s applications of increasing concentrations of the agonist in the
continued presence of menthol. Between each drug application a 2min
wash off time was allowed, and the responses were normalized to the
control 100 μM acetylcholine current.
In order to characterize the antagonist properties of the phyto-
compounds, a control concentration of 100 μM ACh was first applied for
30 s followed by a 2min wash with recording solution. Thereafter,
100 μM acetylcholine was applied for 10 s, immediately followed by
10 s application of the antagonist (100 μM) in the continued presence of
100 μM ACh and then a final 10 s application of 100 μM ACh. At least
2min drug wash off interval was allowed between applications in order
to minimize desensitization. Note that the potency for each antagonist
is likely to be slightly underestimated due to the short time of drug
application with this approach (Abongwa et al., 2016a). Acetylcholine
concentration-response relationships in the presence of 100 μM limo-
nene oxide and 100 μM carvacrol were generated by first applying a
control 100 μM acetylcholine for 10 s, followed by a 2-min application
of the antagonist, and 10 s applications of 3, 10, 30, 100 and 300 μM
acetylcholine in the continued presence of antagonist. The responses
were normalized to the control 100 μM acetylcholine current.
2.5. Data and statistical analysis
Data acquired from electrophysiological recordings were analyzed
with Clampfit 10.3 (Molecular Devices, Sunnyvale, CA, USA) and
GraphPad Prism 7.0 (Graphpad Software Inc., La Jolla, CA, USA). The
peak current responses in oocytes to applied drugs were normalized to
the 100 μM ACh control current (unless otherwise indicated) and ex-
pressed as mean ± SEM. All completed drug application sequences on
the oocytes were used for analysis without exclusion. If the recording
became unstable, indicated by a change in the baseline holding current,
all of that recording was rejected for analysis. The mean % inhibition
produced by monoterpenoid compounds on currents elicited by 100 μM
acetylcholine were calculated as previously described (Zheng et al.,
2016). For A. suum contraction experiments, mean contraction re-
sponses in grams (g) to each concentration of acetylcholine in the ab-
sence and presence of menthol was determined. The sigmoidal con-
centration-responses for the oocyte experiments and isometric
contraction studies were described using the following equation:
% response = 1/1+[EC50/Xa]nH
where EC50 is the concentration of agonist (Xa) producing 50% of the
maximum response and nH is the Hill coefficient (slope). Differences in
pEC50 and Imax were assessed using extra sum of squares F-test. Two-
way ANOVA and paired t-tests were used to test differences between
control contractions and test contractions on the same muscle flap. The
difference was considered significant if P < 0.05.
3. Results
3.1. Pharmacology of monoterpenoids on Ode (29-38-63-8) receptor
3.1.1. Agonist pharmacology
The agonist properties of 12 monoterpenoid compounds were in-
vestigated on the levamisole sensitive Ode-unc-29∶Ode-unc-38∶Ode-unc-
63∶Ode-acr-8 nAChR (Fig. 2). 11 of the 12 monoterpenoids we tested
showed no significant agonistic effect (< 1.0% of control acetylcholine
current; Fig. 2A) on the expressed levamisole sensitive channel. Men-
thol was the only compound tested that produced an agonist effect,
showing only ≈6.5% of the control acetylcholine currents.
3.1.2. Antagonist pharmacology
We tested potential antagonistic effects of the same 12 mono-
terpenoids on the levamisole sensitive receptor (Fig. 3). Among all the
phytocompounds tested limonene oxide, citronellol, carvone, carvacrol,
pulegone and eugenol reduced the acetylcholine response. Limonene
oxide was the most potent inhibitor (mean inhibition%=36.0 ±
3.2%). The rank order potency of inhibition was: limonene oxide >
citronellol > carvone > carvacrol=pulegone= eugenol (Fig. 3A).
Interestingly, monoterpenoids including menthol, menthone, menthyl
acetate and geraniol increased the amplitude of currents produced by
acetylcholine instead of inhibiting them (data not shown). Menthol
produced the most potent positive allosteric modulation and increased
the response by 3.1 ± 0.7% (mean ± SEM) with a maximum po-
tentiation of 6.3%.
3.1.3. Antagonistic effects of limonene oxide and carvacrol on acetylcholine
concentration-response relationship
The concentration-response relationship for acetylcholine was
Fig. 2. Agonist effects of monoterpenoid compounds on levamisole sensitive O.
dentatum nAChR. A. Sample traces for the agonist experiment. B. Bar chart
(expressed as mean ± SEM%) showing agonistic effects of the monoterpenoid
compounds: menthol (6.5 ± 2.4%, n= 6), geraniol (0.9 ± 0.2%, n= 6),
cinnamaldehyde (0.6 ± 0.2%, n=6), citronellol (0.4 ± 0.2%, n=6), men-
thyl acetate (0.3 ± 0.1%, n= 6), eugenol (0.3 ± 0.2%, n= 6), phenethyl
propionate (0.3 ± 0.1%, n= 6), limonene oxide (0.3 ± 0.2%, n= 6), carva-
crol (0.2 ± 0.2%, n= 6), menthone (0.2 ± 0.1%, n= 6), pulegone
(0.1 ± 0.1%, n= 6) and carvone (0.0 ± 0.0%, n= 6).
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examined by applying increasing concentrations of acetylcholine
0.3–300 μM to oocytes expressing the levamisole sensitive nAChR
(Fig. 3B and C). The sigmoidal concentration-response fit gave
pEC50=5.3 ± 0.0 (EC50=5.3 μM), a hillslope (nH) of 2.0 ± 0.2 and
Imax value of 104.6 ± 1.6%. We investigated the effects of limonene
oxide (100 μM) and carvacrol (100 μM) on the acetylcholine con-
centration-response relationship. Imax for acetylcholine in the presence
of limonene oxide and carvacrol were 62.8 ± 7.0% and 74.1 ± 3.2%,
respectively. Both the monoterpenoid compounds produced a statisti-
cally significant reduction in the maximum response (P < 0.001 for
limonene oxide; P < 0.0001 for carvacrol; Fig. 3B and C). Neither
carvacrol, pEC50=5.7 ± 0.1 (EC50=2.0 μM) nor limonene oxide,
pEC50=5.4 ± 0.2 (EC50=4.0 μM) increased the EC50 values c.f.
control. This indicates limonene oxide and carvacrol both produced
non-competitive inhibition and are not binding at the agonist-binding
site to produce their effect.
3.1.4. Menthol as positive allosteric modulator
Menthol was a weak agonist on the expressed levamisole sensitive
receptor. However, it appeared to potentiate acetylcholine responses in
our antagonist experiments (data not shown). To investigate positive
allosteric modulation further, we analyzed the effect of menthol on
acetylcholine and levamisole concentration-response relationships
(Fig. 4 and Fig. 5). We observed a left shift in the sigmoidal con-
centration-response curves for both levamisole and acetylcholine in the
presence of menthol. Sensitivity of the receptor was increased sig-
nificantly for acetylcholine, pEC50=5.3 ± 0.0 (EC50=5.0 μM); in the
presence of 0.1 μM menthol, pEC50=6.4 ± 0.1 (EC50=0.4 μM) and
with 10 μM menthol, pEC50=6.5 ± 0.1 (EC50=0.3 μM).
For levamisole alone, pEC50 and EC50 values were 6.3 ± 0.1 and
0.5 μM respectively. In the presence of 0.1 μM menthol pEC50 and EC50
values were 6.5 ± 0.1 and 0.3 μM respectively. In the presence of
10 μM menthol the pEC50 and EC50 values were 6.8 ± 0.2 and 0.2 μM.
Only 10 μM menthol produced a significant left shift in the levamisole
concentration-response curve (P < 0.05; Fig. 5C). The positive allos-
teric modulation produced by menthol was more pronounced with
acetylcholine as an agonist in comparison to levamisole. In conclusion,
menthol not only acts as an agonist on the levamisole sensitive receptor
but also displays significant PAM activity on this nAChR.
3.2. Effects of menthol and carvacrol on A. suum ACR-16 nAChR
Fig. 6 shows the concentration-response relationship for acet-
ylcholine on the expressed Asu-ACR-16 nicotine sensitive nAChR. The
sigmoidal concentration-response fit gave pEC50=5.0 ± 0.1
(EC50=11.1 μM), Imax= 109.1 ± 6.6% and a hillslope (nH) of
1.6 ± 0.3. We investigated the effects of menthol (10 μM) and carva-
crol (10 μM and 100 μM) on the acetylcholine response. There was no
Fig. 3. Effect of monoterpenoid compounds as antagonists on levamisole sen-
sitive O. dentatum receptor acetylcholine mediated responses. A. Bar graph
showing the rank order potency of monoterpenoid compounds as antagonists.
Results were expressed as % mean inhibition ± SEM of currents elicited by
100 μM ACh: limonene oxide (36.0 ± 3.2%, n=6) > citronellol
(18.0 ± 1.6%, n=6) > carvone (14.0 ± 0.6%, n=6) > carvacrol
(11.0 ± 1.6%, n= 6)= pulegone (11.0 ± 2.6%, n= 6)= eugenol
(11.0 ± 1.0%, n= 6). Inset: image showing predicted acetylcholine response
in the absence of limonene oxide (dotted line) and inhibition of acetylcholine
mediated response in the presence of limonene oxide (highlighted in green). B.
Acetylcholine current responses, recorded from the Xenopus oocyte expressing
the levamisole sensitive channel, alone and in the presence of 100 μM carvacrol
(n= 6) & 100 μM limonene oxide (n=5). C. Concentration-response plots for
acetylcholine alone (n=6, black) and acetylcholine in the presence of 100 μM
carvacrol (n= 6, maroon) & 100 μM limonene oxide (n=5, green). pEC50
(mean ± SEM), EC50 (mean, μM), Hill slope (nH) (mean ± SEM) and Imax
(mean ± SEM%) values were respectively: 5.3 ± 0.0, 5.3 μM, 2.0 ± 0.2 and
104.6 ± 1.6 for acetylcholine alone; 5.4 ± 0.2, 4.0 μM, 2.2 ± 1.7 and
62.8 ± 7.0 in the presence of limonene oxide; 5.7 ± 0.1, 2.0 μM, 1.7 ± 1.1
and 74.1 ± 3.2 in the presence of carvacrol. Bottom was constrained to zero
for curve fitting. (For interpretation of the references to colour in this figure
legend, the reader is referred to the Web version of this article.)
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significant change in the sensitivity or efficacy of acetylcholine on the
N-type receptor in the presence of menthol (pEC50=5.0 ± 0.1 and I
max= 101.6 ± 7.5%). The concentration-response fits (Fig. 6C) show
that 100 μM carvacrol decreased the maximum response while 10 μM
carvacrol failed to exhibit any significant antagonistic properties. In the
presence of 10 μM carvacrol pEC50, EC50 and Imax values were
5.1 ± 0.1, 8.1 μM and 94.6 ± 5.9% respectively. Carvacrol produced
a significant reduction in Imax (55.8 ± 4.4%; P < 0.05) when applied
at 100 μM concentration but did not produce a significant right shift in
the pEC50 (5.1 ± 0.1). This indicates carvacrol at 100 μM produced
non-competitive inhibition.
3.3. Effect of menthol on A. suum muscle
We examined the effect of menthol on the A. suum muscle flap
contractions induced by increasing concentrations of acetylcholine.
Fig. 7A shows the representative trace for acetylcholine, in the absence
and presence of 0.1 μM menthol in the experimental bath. Acetylcho-
line produced concentration-dependent isometric contractions with a
pEC50 of 5.2 ± 0.2 (EC50=7.0 μM) and Rmax= 1.7 ± 0.2 g. We did
not observe a significant left shift in pEC50 (5.2 ± 0.2) or change in
Rmax (2.0 ± 0.2 g) in the presence of menthol. As expected, based on
two-way ANOVA, acetylcholine concentration had a significant effect
on muscle contraction (P < 0.0001). Importantly the presence of
menthol also had a significant effect on muscle contraction
(P < 0.0001). Further analysis revealed a significant potentiation of
contractions at each concentration of acetylcholine in the presence of
menthol (paired t-tests, P<0.05, Fig. 7B for examples). This mod-
ulatory effect of menthol is similar to our observed effects on the le-
vamisole sensitive receptor.
4. Discussion
Monoterpenoids are a group of plant secondary metabolites that
have been shown to modulate the function of nicotinic acetylcholine
receptors of mammals and insects (Lozon et al., 2016; Park et al., 2001,
2003; Tong et al., 2013). We were interested in finding possible ago-
nists, antagonists or modulators for these cys loop receptors of parasitic
nematodes. In this study, we provide evidence of significant modulatory
effects of several monoterpenoid compounds on the levamisole sensi-
tive O. dentatum receptor and nicotine sensitive A. suum nAChR. We
chose to use the levamisole sensitive nAChR from O. dentatum due to
unreliable expression of the levamisole sensitive nAChR from A. suum in
our hands.
The majority of the phytocompounds tested failed to exhibit agonist
properties on the nAChRs but we were able to identify inhibitors of the
levamisole sensitive nematode receptor with a rank order:
limonene oxide > citronellol > carvone > carvacrol= pulegone=
eugenol.
Fig. 4. Effects of menthol as a PAM on levamisole sensitive O. dentatum nAChR
acetylcholine responses. A. Sample traces for two-electrode voltage-clamp re-
cording showing inward currents in response to ascending concentrations of
acetylcholine alone, acetylcholine in the presence of 0.1 μM and 10 μM men-
thol. B. Concentration-response relationships for acetylcholine alone (n= 7,
black), acetylcholine in the presence of 0.1 μM (n=6, blue) and 10 μMmenthol
(n= 7, purple). pEC50 (mean ± SEM), EC50 (mean, μM), Hill slope (nH)
(mean ± SEM) and Imax (mean ± SEM%) values were respectively:
5.3 ± 0.0, 5.0 μM, 1.4 ± 0.1 and 107.5 ± 2.6 for acetylcholine alone;
6.4 ± 0.1, 0.4 μM, 1.0 ± 0.1 and 109.0 ± 3.6 in the presence of 0.1 μM
menthol; 6.5 ± 0.1, 0.3 μM, 1.0 ± 0.1 and 110.5 ± 3.7 in the presence of
10 μM menthol. Bottom was constrained to zero for curve fitting. C. Bar chart
showing comparison of pEC50 (expressed as mean ± SEM) for acetylcholine in
the presence and absence of menthol. ****P < 0.0001; significantly different
as indicated; extra sum of squares F-test. (For interpretation of the references to
colour in this figure legend, the reader is referred to the Web version of this
article.)
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Limonene oxide and carvacrol produced significant non-competitive
inhibition suggesting neither compound acts at the ligand binding sites.
Limonene oxide is a monoterpene found in essential oils of various ci-
trus fruits and is an odorous component of some types of mushrooms
(Breheret et al., 1997; Lemes et al., 2018; Lota et al., 2002; Rapior et al.,
1997; Vieira et al., 2018); it has been reported to stimulate TRPA1
cation channels (Kaimoto et al., 2016). There are limited data available
on the effects of limonene oxide on nAChRs and this is the first example
of an antagonistic effect of the compound on a levamisole sensitive
nematode nAChR. According to a study done by Kim et al. (2013) li-
monene oxide was reported to be a safe phytochemical in mammals and
thus could be used in combination with other nicotinic inhibitors for
anti-nematodal therapy. Carvacrol, found in many plants including
thyme, oregano and Alaska yellow cedar (Bouchra et al., 2003; De
Vincenzi et al., 2004); acted as a non-competitive inhibitor on both
levamisole sensitive and nicotine sensitive nematode receptors. Various
studies have shown alpha-7 homomeric nAChRs, GABA (gamma amino-
butyric acid) and tyramine receptors as target sites for carvacrol (Lozon
et al., 2016; Tong and Coats, 2012; Tong et al., 2013). In addition,
carvacrol was shown to produce significant inhibitory effects on acet-
ylcholine induced muscle contractions in A. suum (Trailović et al.,
2015). This polypharmacological effect of carvacrol might make it ef-
ficacious as an anthelmintic phytotherapeutic, although it may be best
considered as an adjunct to other anti-nematodal compounds to in-
crease efficacy due to toxicity considerations when used alone at high
concentrations (Bimczok et al., 2008; Roselli et al., 2007; Stammati
et al., 1999).
The most interesting finding was the positive allosteric modulatory
activity of menthol on the levamisole sensitive nematode nAChR.
Menthol is a monocyclic terpene alcohol extracted from peppermint
plants, Mentha spp. and regulates somatosensory sensations such as
warmth, pain and irritation (Cliff and Green, 1994; Eccles, 1994; Farco
and Grundmann, 2013). Menthol showed very mild agonist activity but
produced statistically significant potentiation of acetylcholine induced
inward currents at concentrations as low as 0.1 μM and of levamisole
induced currents at 10 μM on the levamisole sensitive cation channel.
PAM compounds exhibit potentiation of the agonist-activation effects
by binding to a site distinct from the ligand binding sites. This property
is highly desired in drug discovery and development as PAMs can
achieve subtype selectivity more easily in comparison to compounds
binding to orthosteric sites (Chatzidaki and Millar, 2015; Williams
et al., 2011) as all the nAChRs have highly conserved acetylcholine
binding sites. In comparison, the conservation for amino acid compo-
sition for other sites is less which makes PAMs preferable in terms of
selectivity and reduced potential off target effects (Chatzidaki and
Millar, 2015; Williams et al., 2011). Menthol modulates the
Fig. 5. Effects of menthol on levamisole sensitive nAChR levamisole responses.
A. Representative current traces for two-electrode voltage-clamp recording
showing inward currents in response to ascending application of levamisole
alone, levamisole in the presence of 0.1 μM and 10 μM menthol. B.
Concentration-response relationships for levamisole alone (n=7, steel gray)
and in the presence of 0.1 μM (n= 6, light green) and 10 μM menthol (n= 7,
dark green). pEC50 (mean ± SEM), EC50 (mean, μM), Hill slope (nH)
(mean ± SEM) and Imax (mean ± SEM%) values were respectively:
6.3 ± 0.1, 0.5 μM, 1.0 ± 0.2 and 96.3 ± 5.2 for levamisole alone; 6.5 ± 0.1,
0.3 μM, 1.1 ± 0.2 and 94.6 ± 5.0 in the presence of 0.1 μM menthol;
6.8 ± 0.2, 0.2 μM, 1.0 ± 0.2 and 89.2 ± 6.0 in the presence of 10 μM men-
thol. Bottom was constrained to zero for curve fitting. C. Bar chart summarizing
the results showing comparison of pEC50 (expressed as mean ± SEM) for le-
vamisole in the presence and absence of menthol. *P < 0.05; significantly
different as indicated; extra sum of squares F-test. (For interpretation of the
references to colour in this figure legend, the reader is referred to the Web
version of this article.)
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pharmacological properties and expression of vertebrate nicotinic
acetylcholine receptors; it inhibits the effect of nicotine on α7-nACh
receptors in neural cells in a non-competitive manner (Ashoor et al.,
2013; Hans et al., 2012; Ton et al., 2015). However, it is worth noting
that these negative allosteric modulatory and inhibitory effects of
menthol on α7-nACh receptors were produced by much higher con-
centrations (30–300 μM) in comparison to our study. In addition,
menthol at 10 μM had no significant effect on the nematode nicotine
sensitive nAChR (the closest ortholog to vertebrate α7-nAChRs in the
nematodes). This makes menthol an interesting candidate that can
potentiate the effects of cholinergic agonist anthelmintics acting on
levamisole sensitive nAChRs. Importantly, 0.1 μM menthol produced
significant potentiation of contractions produced by acetylcholine on A.
suum muscle flaps. The presence of positive allosteric modulation in the
somatic muscle flap preparation can be attributed to the presence of
levamisole receptors and is important in vivo confirmation of our
findings from the in vitro heterologous expression studies.
5. Conclusion
Natural products have formed the basis of sophisticated traditional
therapies and they continue to play essential roles in modern health-
care. Phytocompounds, with their complex chemistry and structural
diversity, offer the potential for discovery and development of new
pharmaceuticals. Botanical anthelmintics may reduce the need for
chemical drug treatment and alleviate the pressure on the limited group
of anthelmintics available. Carvacrol produced significant antagonism
on the acetylcholine induced inward currents on both levamisole sen-
sitive and nicotine sensitive nematode ligand gated ion channels. This
illustrates a multifaceted mode of action with involvement of multiple
target subtypes that can help ameliorate the issue of drug resistance. It
may be possible to combine these compounds with the nAChR an-
tagonist derquantel or perhaps with a macrocyclic lactone as with
Startect® (derquantel + abamectin).
Our results provide promising evidence of positive allosteric mod-
ulation by menthol which could be used in combination therapy with
cholinomimetic drugs like pyrantel or levamisole to increase efficacy.
For future investigations menthol could be used as the starting point in
structure activity relationship studies to find new potent PAM com-
pounds suitable for stand-alone use as anthelmintics. In summary, the
use of plant derived compounds, either alone or in combination, could
facilitate sustainable control of parasitic nematodes. The results of the
present study are encouraging and suggest monoterpenoids can be
exploited as components of new anthelmintic formulations.
Fig. 6. Effects of menthol and carvacrol on nicotine sensitive A. suum ACR-16
nAChR acetylcholine responses. A. Representative current traces for two-elec-
trode voltage-clamp recording showing inward currents in response to in-
creasing acetylcholine concentrations in the presence of menthol (10 μM) and
carvacrol (10 μM and 100 μM) B. Concentration-response plot for acetylcholine
alone (n= 7, black) and acetylcholine in the presence of menthol (n= 6, red).
pEC50 (mean ± SEM) and EC50 (mean, μM) values were respectively:
5.0 ± 0.1 and 11.1 μM for acetylcholine alone, 5.0 ± 0.1 and 9.5 μM in the
presence of 10 μM menthol. Hill slope (nH) (mean ± SEM) values were:
1.6 ± 0.3 for acetylcholine alone; 2.5 ± 1.2 in the presence of 10 μM men-
thol. Imax (mean ± SEM%) values were: 109.1 ± 6.6 for acetylcholine alone;
101.6 ± 7.5 in the presence of 10 μM menthol. Bottom was constrained to zero
for curve fitting. C. Concentration-response plots for acetylcholine alone (n= 7,
black) and in the presence of carvacrol (n= 6, blue). pEC50 (mean ± SEM),
EC50 (mean, μM), Hill slope (nH) (mean ± SEM) and Imax (mean ± SEM%)
values were respectively: 5.1 ± 0.1, 8.1 μM, 2.5 ± 0.8 and 94.6 ± 5.9 in the
presence of 10 μM carvacrol; 5.1 ± 0.1, 8.2 μM, 2.0 ± 0.7 and 55.8 ± 4.4 in
the presence of 100 μM carvacrol. Bottom was constrained to zero for curve
fitting. (For interpretation of the references to colour in this figure legend, the
reader is referred to the Web version of this article.)
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